Evidence map›Paper›PMID 29567240›Full record

ArticleJournal of food and drug analysis2018

Production of antioxidant and ACE-inhibitory peptides from Kluyveromyces marxianus protein hydrolysates: Purification and molecular docking.

Mahta Mirzaei, Saeed Mirdamadi, Mohamad Reza Ehsani, Mahmoud Aminlari

Open access · hybridAbstract read
In one paragraph

Article in Journal of food and drug analysis, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 157 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Multiple Bioactivities of Peptides from HydrolyzedMolecules (Basel, Switzerland) · 2023
    Article
  19. ACE Inhibitory Peptides Derived from Muscovy Duck (Foods (Basel, Switzerland) · 2022
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 4 institutions in 1 country.

Mahta MirzaeiDepartment of Food Science and Technology, Shahr-e-Qods Branch, Islamic Azad University, Tehran, Iran.
Saeed MirdamadiDepartment of Biotechnology, Iranian Research Organization for Science & Technology (IROST), Tehran, Iran.
Mohamad Reza EhsaniDepartment of Food Science and Technology, Science and Research Branch, Islamic Azad University, Tehran, Iran.
Mahmoud AminlariDepartment of Biochemistry, School of Veterinary Medicine, Shiraz University, Shiraz, Iran.
Iranian Research Organization for Science and Technology · IRIslamic Azad University, Science and Research Branch · IRIslamic Azad University, Shahr-e-Qods Branch · IRShiraz University · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Kluyveromyces marxianus protein hydrolysates were prepared by two different sonicated-enzymatic (trypsin and chymotrypsin) hydrolysis treatments to obtain antioxidant and ACE-inhibitory peptides. Trypsin and chymotrypsin hydrolysates obtained by 5 h, exhibited the highest antioxidant and ACE-inhibitory activities. After fractionation using ultrafiltration and reverse phase high performance liquid chromatography (RP-HPLC) techniques, two new peptides were identified. One fragment (LL-9, MW = 1180 Da) with the amino acid sequence of Leu-Pro-Glu-Ser-Val-His-Leu-Asp-Lys showed significant ACE inhibitory activity (IC

Indexed as

Amino Acid SequenceAngiotensin-Converting Enzyme InhibitorsAntioxidantsHumansKluyveromycesMolecular Docking SimulationMolecular Sequence DataPeptide MappingPeptidesPeptidyl-Dipeptidase AProtein HydrolysatesAngiotensin-Converting Enzyme InhibitorsAntioxidantsPeptidesPeptidyl-Dipeptidase AProtein HydrolysatesACE inhibitoryAntioxidantBioactive peptidesK. marxianusProtein hydrolysate

Identifiers

PMID29567240
PMCPMC9322238
OpenAlexW2746871355

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.